4.1 Review

Measuring prognosis in chronic myeloid leukemia: what's new?

Journal

EXPERT REVIEW OF HEMATOLOGY
Volume 14, Issue 6, Pages 577-585

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/17474086.2021.1938534

Keywords

Chronic myeloid leukemia; prognostic scores; chromosome abnormalities; prognosis; survival

Categories

Ask authors/readers for more resources

Prognostic factors examined at baseline are crucial for evaluating long-term disease-related death probability, potential toxicities, and projected overall survival. Genomic assessment offers a genomic-based risk stratification and aids in decision-making process based on patient's specific conditions.
Introduction: The outcome of chronic myeloid leukemia (CML) patients in chronic phase has changed after the introduction of tyrosine kinase inhibitors (TKIs). The life expectancy is actually similar to that of the general population. Prognostic stratification at baseline is part of a patient-centered approach to decide the best therapeutic approach. Areas covered: In this review, the current prognostic factors examined at baseline are detailed and the meaning is explained. A broad research on Medline, Embase and archives from EHA and ASH congresses, was performed. Prognostic factors have been divided into patient-related (age, gender, comorbidities, etc.) and disease-related (additional cytogenetic abnormalities, type of transcript, etc). New information about genomic data and the potential role of patient-reported outcomes is also discussed. Expert Opinion: Prognostic factors at baseline should be considered to evaluate the long-term probability of disease-related death, the possible toxicity, and the projected long-term overall survival. The genomic assessment would provide the basis for a genomic-based risk and help in oriented decision-making process.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available